The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer.

Authors: Hermán-Sánchez, Natalia, G-García, Miguel E., Jiménez-Vacas, Juan M., Yubero-Serrano, Elena M., López-Sánchez, Laura M., Romero-Martín, Sara, Raya-Povedano, Jose L., Álvarez-Benito, Marina, Castaño, Justo P., Luque, Raúl M., Gahete, Manuel D.

Source: Cellular & Molecular Life Sciences; 12/27/2024, Vol. 82 Issue 1, p1-16, 16p

Subject Terms: MEDICAL sciences, HORMONE receptors, OVERALL survival, BREAST cancer, CELL lines, RNA splicing, BREAST